Third quarter results 2014

Third quarter results 2014

Sanofi delivers Business EPS growth of 10.3% at CER in Q3 2014

Third quarter results 2014 were reviewed by management during a conference call. The presentation was followed by a Q&A session.

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies
OK